Literature DB >> 4001591

Macular edema following panretinal photocoagulation.

H R McDonald, H Schatz.   

Abstract

The authors reviewed the preoperative, postoperative, and follow-up examinations, fundus photographs, and fluorescein angiograms of 175 eyes with proliferative diabetic retinopathy treated with panretinal photocoagulation. Seventy-five (43%) of the treated eyes developed increased macular edema 6-10 weeks following laser treatment. Follow-ups ranged from 3 months to 48 months, with a median follow-up of 15 months. Fluorescein angiography revealed that the postlaser increase in macular edema persisted in 47 of the 175 eyes (27%). Fourteen eyes (8%) treated with laser developed chronic macular edema and visual loss of two or more lines. Inflammation and altered retinal blood flow are possible pathogenetic mechanisms responsible for the development of postpanretinal photocoagulation macular edema.

Entities:  

Mesh:

Year:  1985        PMID: 4001591     DOI: 10.1097/00006982-198500510-00002

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  33 in total

1.  Effect of grid laser photocoagulation in diffuse diabetic macular edema in correlation to glycosylated haemoglobin (HbA1c).

Authors:  Katharina E Schmid; Beatrix Neumaier-Ammerer; Ulrike Stolba; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-04-07       Impact factor: 3.117

2.  Change in subfoveal choroidal thickness after argon laser panretinal photocoagulation.

Authors:  Ga Eun Cho; Hee Yun Cho; Yun Taek Kim
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

3.  The effect of short versus long exposure times of argon laser panretinal photocoagulation on proliferative diabetic retinopathy.

Authors:  E C Wade; G W Blankenship
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

4.  Pain score of patients undergoing single spot, short pulse laser versus conventional laser for diabetic retinopathy.

Authors:  Ahmad Mirshahi; Alireza Lashay; Mehdi Roozbahani; Masoud Aghsaei Fard; Saber Molaie; Meysam Mireshghi; Mohamad Mehdi Zaferani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-11       Impact factor: 3.117

5.  The change of macular thickness following single-session pattern scan laser panretinal photocoagulation for diabetic retinopathy.

Authors:  Jong-Hyun Oh; Seong-Woo Kim; Soon-Sun Kwon; Jaeryung Oh; Kuhl Huh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-27       Impact factor: 3.117

6.  The origin of macular cysts in diabetic maculopathy.

Authors:  D W Flanagan
Journal:  Br J Ophthalmol       Date:  1995-07       Impact factor: 4.638

Review 7.  A review of anti-VEGF agents for proliferative diabetic retinopathy.

Authors:  P Osaadon; X J Fagan; T Lifshitz; J Levy
Journal:  Eye (Lond)       Date:  2014-02-14       Impact factor: 3.775

8.  Subclinical macular findings in infants screened for retinopathy of prematurity with spectral-domain optical coherence tomography.

Authors:  Adam M Dubis; C Devika Subramaniam; Pooja Godara; Joseph Carroll; Deborah M Costakos
Journal:  Ophthalmology       Date:  2013-05-11       Impact factor: 12.079

9.  Laser photocoagulation combined with intravitreal triamcinolone acetonide injection in proliferative diabetic retinopathy with macular edema.

Authors:  Kyung Seek Choi; J K Chung; Sang Hyun Lim
Journal:  Korean J Ophthalmol       Date:  2007-03

10.  Effects of an intravitreal bevacizumab injection combined with panretinal photocoagulation on high-risk proliferative diabetic retinopathy.

Authors:  Yong Woon Shin; Yoon Jung Lee; Byung Rho Lee; Hee Yoon Cho
Journal:  Korean J Ophthalmol       Date:  2009-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.